+ Equity
1-2 days a week in office (NYC, New York)
AI-powered patient recruitment for clinical trials
Posted today
AI-powered patient recruitment for clinical trials
21-100 employees
Posted today
+ Equity
1-2 days a week in office (NYC, New York)
21-100 employees
To bring clinical research to each and every patient, regardless of who they are and where they live.
Desirable
Inato is a platform that helps biopharmaceutical companies increase the pool of available patients engaged in clinical trials. The platform discovers the best healthcare sites for any given study, combining trial planning, site selection and patient pre-screening into an AI-enabled platform, ensuring its partners successfully deliver trials.
The platform was built to help physicians navigate the increasingly complex research environment, enhancing trial accessibility and representation. It also helps customers to discover research opportunities and streamline trial processes, stepping away from the industry standard of matching patients directly with trials and instead matching companies with community sites. In turn, this diversifies the patients who are available for studies.
Backed by leading global venture capital firms such as Cathay Innovation, Obvious Ventures, La Maison Partners, and Top Harvest Capital, Inato's funding has helped it scale with speed and confidence.
Kirsty
Company Specialist at Welcome to the Jungle
6 people
Meet Julia, Senior Manager Customer Success
Inspiring mission
"As someone who has worked at clinical research sites and witnessed firsthand the limited access to trials, I joined Inato because I was drawn to its..."
Mar 2023
$20m
SERIES A
Feb 2020
$14m
SERIES A
Jean-David Zeitoun
(Co-Founder & Chief Medical Officer)Medical Doctor with a degree from Sciences Po, with a PhD in Clinical Epidemiology. Also an advisor for health industries and investment funds since 2010.
Kourosh Davarpanah
(Co-Founder & CEO)They were formerly a Co-Founder at Fleet Impact, and worked in Cryptocurrency Design at NeuCoin.
Liz Beatty
(Co-Founder & Chief Strategy Officer)Alongside Inato, they have been a Managing Partner at H&N Investment Management since 2019. They Previously spent over 15 years at Bristol-Myers Squibb in various Directorial roles.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job